Healthy volunteers help test new combo pill for heart health
NCT ID NCT06889012
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study tested how the body processes three experimental drugs (BR1018, BR1018A, and BR1018B) in 60 healthy adults. The goal was to measure drug levels and check safety, not to treat any condition. Results will guide future studies for high blood pressure and high cholesterol.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BR1018, BR1018A, BR1018B (drug tablets)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Center, H PLUS Yangji Hospital
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a heart drug be a new key to controlling high blood pressure?
- A simple arm cuff may lower blood pressure without drugs
- AI tailors blood pressure drugs, outsmarting One-Size-Fits-All medicine
- Herbal capsule aims to tackle both high blood pressure and poor sleep
- New drug combo aims to tame stubborn high blood pressure
- New combo pill aims to tame stubborn high blood pressure